Search filters

List of works by Murielle Roussel

'Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury'

scientific article published on 01 June 2016

A macroglobulinemia with an unusual bone marrow aspect

scientific article published in June 2001

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

scientific article

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients

scientific article published on 11 April 2014

Aggressive FLC Escape in a Patient with IgD Myeloma.

scientific article

An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis

scientific article published on December 2014

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.

scientific article published on 16 August 2013

Bioactivity and prognostic significance of growth differentiation factor GDF15 secreted by bone marrow mesenchymal stem cells in multiple myeloma.

scientific article published on 2 February 2012

Bortezomib and heart failure: case-report and review of the French Pharmacovigilance database.

scientific article published on 19 June 2013

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).

scientific article published on 2 November 2009

Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).

scientific article published on 19 July 2010

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

scientific article

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

scientific article published on 03 June 2019

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

scientific article published on 03 May 2019

Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosis

scientific article published on 18 June 2013

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma

scientific article published on 05 April 2013

Crowded bone marrow plasma cells

scientific article published on 01 January 2020

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience

scientific article published on 29 July 2011

DKK1 and sclerostin are early markers of relapse in multiple myeloma.

scientific article

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

scientific article

Diagnosis of monoclonal gammopathy of renal significance

scientific article

Dual-energy X-ray absorptiometry and biochemical markers of bone turnover after autologous stem cell transplantation in myeloma

scientific article published on 21 February 2012

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

scientific article published on 19 December 2019

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III).

scientific article

Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients

scientific article

European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis

scientific article

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

scientific article published on 17 November 2017

Firstline treatment and maintenance in newly diagnosed multiple myeloma patients.

scientific article published on January 2011

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du

scientific article published on 14 July 2014

Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma

scientific article published on 22 February 2020

High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a

scientific article

Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma

scientific article published on 11 December 2015

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

scientific article published on 01 May 2012

Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study

scientific article published on 19 August 2010

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.

scientific article published on April 2017

Maintenance therapy for myeloma: how much, how long, and at what cost?

scientific article published on 01 January 2012

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group

scientific article published on 29 December 2015

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow

scientific article published on 01 November 2018

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation

scientific article published on 11 March 2014

Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera

article

Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma

scientific article published on 17 March 2015

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

scientific article published on 14 November 2014

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.

scientific article published on 30 May 2016

Pomalidomide for multiple myeloma

scientific article published on 6 August 2015

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results

scientific article published on 9 January 2015

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02.

scientific article

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma

scientific article published on 03 October 2018

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

scientific article published on August 2015

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience

scientific article

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma.

scientific article published on 19 January 2016

Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.

scientific article published on 12 January 2018

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

scientific article published on 11 October 2016

Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival

scientific article published on March 2011

Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units.

scientific article published on 12 June 2016

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting

scientific article published on 5 September 2014

UMOD genetic variations and myeloma cast nephropathy

scientific article published on 15 June 2019

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

scientific article

VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial

scientific article

[Multiple bone myelomas]

scientific article published on 01 October 2009

[Multiple myeloma treatment]

scientific article published on 01 September 2018

Paulina is supported by:

About Paulina

Help